| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
529 |
516 |
$53K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
545 |
530 |
$39K |
| 99152 |
|
396 |
371 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
549 |
528 |
$16K |
| 72100 |
|
321 |
309 |
$10K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
29 |
28 |
$731.33 |
| 20610 |
|
13 |
13 |
$586.68 |
| 72040 |
|
15 |
14 |
$544.48 |
| 99153 |
Mod sedat endo service >5yrs |
46 |
45 |
$401.21 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
148 |
139 |
$357.67 |
| 96103 |
|
130 |
128 |
$176.70 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
149 |
140 |
$151.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
132 |
124 |
$131.78 |
| 96146 |
|
16 |
16 |
$17.52 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
55 |
54 |
$16.00 |
| J3490 |
Unclassified drugs |
413 |
383 |
$14.48 |
| 81002 |
|
587 |
556 |
$2.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
56 |
50 |
$0.00 |
| 1036F |
|
814 |
763 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
15 |
15 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
475 |
436 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
374 |
347 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
372 |
346 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
478 |
439 |
$0.00 |
| 77003 |
|
555 |
523 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
373 |
346 |
$0.00 |
| 4004F |
|
29 |
29 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
75 |
68 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
29 |
29 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
71 |
66 |
$0.00 |
| G8539 |
Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment |
35 |
33 |
$0.00 |